MarketCap
Facebook
X
TelegramQuartalsbericht 2026-Q1
hinzugefügt 06.05.2026
Repligen Corporation EV 2011-2026 | RGEN
EV Jährlich Repligen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 284 M | 108 M | 126 M | 107 M | 19 M | -333 M | 4.73 B | 2.41 B | 1.35 B | 968 M | 698 M | 771 M | 476 M | 197 M | 117 M | 92.7 M | -5.04 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 4.73 B | -333 M | 712 M |
EV anderer Aktien in der Medizinische Instrumente
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
20.4 B | $ 59.8 | -0.96 % | $ 11.9 B |  USA |
 |
Atrion Corporation
ATRI
|
636 M | - | - | $ 810 M | USA |
 |
Luminex Corporation
LMNX
|
456 M | - | - | $ 1.75 B | USA |
 |
iRhythm Technologies
IRTC
|
5.71 B | $ 115.3 | 1.0 % | $ 3.69 B | USA |
 |
ICU Medical
ICUI
|
3.36 B | $ 119.07 | -3.19 % | $ 2.93 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
631 M | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
170 B | $ 422.83 | -1.22 % | $ 151 B | USA |
 |
Repro Med Systems
KRMD
|
201 M | $ 3.96 | -0.63 % | $ 183 M | USA |
 |
Alcon
ALC
|
7.99 B | $ 63.71 | -0.48 % | $ 40.4 B |  Schweiz |
 |
LeMaitre Vascular
LMAT
|
2.73 B | $ 97.24 | -2.27 % | $ 2.2 B | USA |
 |
Masimo Corporation
MASI
|
10.4 B | $ 178.36 | - | $ 9.51 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
758 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
726 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
66.3 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
6.3 B | - | -0.05 % | $ 10.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
36 M | - | - | $ 28.6 M | USA |
 |
Envista Holdings Corporation
NVST
|
3.62 B | $ 23.53 | -1.34 % | $ 3.95 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
451 M | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
13.4 M | $ 6.0 | -6.69 % | $ 50.9 K | USA |
 |
Haemonetics Corporation
HAE
|
2.76 B | $ 57.22 | 0.18 % | $ 2.88 B | USA |
 |
Isoray
ISR
|
29.3 M | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
4.69 B | $ 142.59 | 0.31 % | $ 6.91 B | USA |
 |
STAAR Surgical Company
STAA
|
895 M | $ 32.51 | 1.56 % | $ 1.61 B | USA |
 |
STERIS plc
STE
|
27.5 B | $ 212.38 | -1.67 % | $ 20.9 B | USA |
 |
Teleflex Incorporated
TFX
|
8.89 B | $ 129.68 | -0.46 % | $ 5.79 B | USA |
 |
InfuSystem Holdings
INFU
|
157 M | $ 8.68 | 0.52 % | $ 179 M | USA |
 |
Microbot Medical
MBOT
|
120 M | $ 1.89 | 1.89 % | $ 86.5 M |  Israel |
 |
Milestone Scientific
MLSS
|
27.7 M | $ 0.33 | -3.06 % | $ 27.1 M | USA |
 |
Merit Medical Systems
MMSI
|
5.51 B | $ 61.52 | -1.66 % | $ 3.64 B | USA |
 |
Utah Medical Products
UTMD
|
117 M | $ 63.27 | -0.68 % | $ 205 M | USA |
 |
West Pharmaceutical Services
WST
|
17.9 B | $ 304.2 | 1.33 % | $ 22 B | USA |
 |
Pulse Biosciences
PLSE
|
1.64 B | $ 24.37 | -10.07 % | $ 1.64 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
6.29 B | $ 9.96 | -4.37 % | $ 1.99 B | USA |
 |
Retractable Technologies
RVP
|
85.7 M | $ 0.67 | -3.48 % | $ 20.1 M | USA |
 |
Pro-Dex
PDEX
|
175 M | $ 60.46 | 3.09 % | $ 199 M | USA |
 |
Predictive Oncology
POAI
|
-5.62 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
989 M | $ 20.35 | -3.37 % | $ 972 M | USA |
 |
Stereotaxis
STXS
|
191 M | $ 1.89 | -3.08 % | $ 172 M | USA |
 |
Baxter International
BAX
|
21.6 B | $ 17.29 | -2.76 % | $ 8.87 B | USA |
 |
ResMed
RMD
|
36.5 B | $ 202.34 | -0.06 % | $ 29.6 B | USA |
 |
AtriCure
ATRC
|
1.55 B | $ 27.89 | -0.92 % | $ 1.33 B | USA |
 |
Harvard Bioscience
HBIO
|
78.6 M | $ 5.27 | -4.53 % | $ 234 M | USA |
 |
NeuroMetrix
NURO
|
8.29 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
396 M | $ 10.87 | -1.45 % | $ 444 M | USA |
 |
Becton, Dickinson and Company
BDX
|
55.5 B | $ 142.87 | -1.11 % | $ 41.1 B | USA |
 |
Nephros
NEPH
|
31.3 M | $ 3.18 | -4.79 % | $ 33.7 M | USA |
 |
OraSure Technologies
OSUR
|
98.2 M | $ 3.07 | 3.9 % | $ 226 M | USA |